J. March

Health Outcomes With Catheter Ablation or Antiarrhythmic Drug Therapy in Atrial Fibrillation: Results of a Propensity-Matched Analysis

M. Reynolds, C. Gunnarsson, S. Hao, 2012, Circulation. Cardiovascular quality and outcomes.

Economic Impact to Employers of Treatment Options for Cardiac Arrhythmias in the US Health System

M. Reynolds, N. Kleinman, Nicholas J Rohrbacker, 2011, Journal of occupational and environmental medicine.

Acute safety outcomes in younger and older patients with atrial fibrillation treated with catheter ablation

M. Reynolds, C. Gunnarsson, S. Hao, 2012, Journal of Interventional Cardiac Electrophysiology.

Healthcare Utilization and Expenditures in Patients with Atrial Fibrillation Treated with Catheter Ablation

G. David, M. Reynolds, C. Gunnarsson, 2012, Journal of cardiovascular electrophysiology.

Resource use and clinical outcomes in patients with atrial fibrillation with ablation versus antiarrhythmic drug treatment

J. Jarman, T. Wong, W. Hussain, 2018, BMC Cardiovascular Disorders.

Stroke rates before and after ablation of atrial fibrillation and in propensity-matched controls in the UK

J. Jarman, T. Wong, W. Hussain, 2017, Pragmatic and observational research.

Mortality, stroke, and heart failure in atrial fibrillation cohorts after ablation versus propensity-matched cohorts

J. Jarman, T. Wong, W. Hussain, 2017, Pragmatic and observational research.

The Effects of Catheter Ablation Therapy on Medication Use and Expenditures in Patients with Atrial Fibrillation

G. David, M. Reynolds, C. Gunnarsson, 2014, Journal of health economics and outcomes research.

The Burden of Atrial Fibrillation and Other Cardiac Arrhythmias in an Employed Population: Associated Costs, Absences, and Objective Productivity Loss

M. Reynolds, N. Kleinman, Nicholas J Rohrbacker, 2010, Journal of occupational and environmental medicine.